-+ 0.00%
-+ 0.00%
-+ 0.00%

Opaleye Management reports $124,453 Grace Therapeutics common share purchase

PUBT·10/05/2026 22:46:49
Listen to the news
Opaleye Management reports $124,453 Grace Therapeutics common share purchase
  • Opaleye Management, a 10% owner of Grace Therapeutics, increased its stake through open-market purchases.
  • Added 60,490 shares at weighted-average prices of $2.0353, $2.0684, and $2.06.
  • Reported ownership rose to 2,858,657 shares, held indirectly through Opaleye, L.P.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grace Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-045809), on October 05, 2026, and is solely responsible for the information contained therein.